Harkesh Dabas
Biographic Data
| ID | 9021872 |
|---|---|
| NAME | Harkesh Dabas |
| GIVEN NAMES | Harkesh |
| FAMILY NAME | Dabas |
| SIGNATURE | DABAS H |
| AFFILIATIONS | Clinton Foundation |
| ORCID | 0009-0006-0219-3282 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Strengthening TB care pathways
Tuberculosis (TB) continues to be the leading cause of death from infectious diseases, disproportionately affecting populations in low- and middle-income countries, where diagnostic and financial barriers impede timely care. While alternative treatments may offer symptomatic relief, the cornerstone of TB management remains anti-tubercular therapy (ATT) as recommended by the World Health Organization (WHO). Yet, many individuals with TB-like sympt…
Understanding why at-risk population segments do not seek care for tuberculosis
INTRODUCTION: Delaying care-seeking for tuberculosis (TB) symptoms is a major contributor to mortality, leading to worse outcomes and spread. To reduce delays, it is essential to identify barriers to care-seeking and target populations most at risk of delaying. Previous work identifies barriers only in people within the health system, often long after initial care-seeking. METHODS: We conducted a community-based survey of 84 625 households in Che…
Field sales force model to increase adoption of a novel tuberculosis diagnostic test among private providers
BACKGROUND: Impact of novel high-quality tuberculosis (TB) tests such as Xpert MTB/RIF has been limited due to low uptake among private providers in high-burden countries including India. Our objective was to assess the impact of a demand generation intervention comprising field sales force on the uptake of high-quality TB tests by providers and its financial sustainability for private labs in the long run. METHODS: We implemented a demand genera…
Increasing coverage of pediatric diarrhea treatment in high-burden countries
BACKGROUND: Diarrhea is the second leading cause of infectious deaths in children under-five globally. Oral rehydration salts (ORS) and zinc could avert an estimated 93% of deaths, but progress to increase coverage of these interventions has been largely stagnant over the past several decades. The Clinton Health Access Initiative (CHAI), along with donors and country governments in India, Kenya, Nigeria, and Uganda, implemented programs to scale-…
No prominent works on this page.
Increasing coverage of pediatric diarrhea treatment in high-burden countries
BACKGROUND: Diarrhea is the second leading cause of infectious deaths in children under-five globally. Oral rehydration salts (ORS) and zinc could avert an estimated 93% of deaths, but progress to increase coverage of these interventions has been largely stagnant over the past several decades. The Clinton Health Access Initiative (CHAI), along with donors and country governments in India, Kenya, Nigeria, and Uganda, implemented programs to scale-…
Understanding why at-risk population segments do not seek care for tuberculosis
INTRODUCTION: Delaying care-seeking for tuberculosis (TB) symptoms is a major contributor to mortality, leading to worse outcomes and spread. To reduce delays, it is essential to identify barriers to care-seeking and target populations most at risk of delaying. Previous work identifies barriers only in people within the health system, often long after initial care-seeking. METHODS: We conducted a community-based survey of 84 625 households in Che…
Field sales force model to increase adoption of a novel tuberculosis diagnostic test among private providers
BACKGROUND: Impact of novel high-quality tuberculosis (TB) tests such as Xpert MTB/RIF has been limited due to low uptake among private providers in high-burden countries including India. Our objective was to assess the impact of a demand generation intervention comprising field sales force on the uptake of high-quality TB tests by providers and its financial sustainability for private labs in the long run. METHODS: We implemented a demand genera…
Strengthening TB care pathways
Tuberculosis (TB) continues to be the leading cause of death from infectious diseases, disproportionately affecting populations in low- and middle-income countries, where diagnostic and financial barriers impede timely care. While alternative treatments may offer symptomatic relief, the cornerstone of TB management remains anti-tubercular therapy (ATT) as recommended by the World Health Organization (WHO). Yet, many individuals with TB-like sympt…
Medicine (3 works) · Nursing (3 works) · Tuberculosis Research and Epidemiology (3 works) · Antibiotic Use and Resistance (2 works) · Environmental health (2 works) · Health care (2 works) · Population (2 works) · Public health (2 works) · Tuberculosis (2 works) · Business (1 work)